JP2019531284A5 - - Google Patents

Info

Publication number

JP2019531284A5

JP2019531284A5 JP2019513745A JP2019513745A JP2019531284A5 JP 2019531284 A5 JP2019531284 A5 JP 2019531284A5 JP 2019513745 A JP2019513745 A JP 2019513745A JP 2019513745 A JP2019513745 A JP 2019513745A JP 2019531284 A5 JP2019531284 A5 JP 2019531284A5

Authority

JP

Japan

Prior art keywords

seq

amino acid

acid sequence

antibody

pd1ab

Prior art date

2017-09-18

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 125000003275 alpha amino acid group Chemical group 0.000 claims description 124
• 239000000427 antigen Substances 0.000 claims description 74
• 102000036639 antigens Human genes 0.000 claims description 74
• 108091007433 antigens Proteins 0.000 claims description 74
• 239000012634 fragment Substances 0.000 claims description 74
• 102100040678 Programmed cell death protein 1 Human genes 0.000 claims description 36
• 101710089372 Programmed cell death protein 1 Proteins 0.000 claims description 36
• 208000023275 Autoimmune disease Diseases 0.000 claims description 32
• 102000004127 Cytokines Human genes 0.000 claims description 24
• 108090000695 Cytokines Proteins 0.000 claims description 24
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 24
• 230000000694 effects Effects 0.000 claims description 18
• 101000611936 Homo sapiens Programmed cell death protein 1 Proteins 0.000 claims description 10
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 10
• 102000048362 human PDCD1 Human genes 0.000 claims description 10
• 208000026278 immune system disease Diseases 0.000 claims description 10
• 201000010099 disease Diseases 0.000 claims description 7
• 101100188738 Astyanax fasciatus G103 gene Proteins 0.000 claims description 6
• 206010039710 Scleroderma Diseases 0.000 claims description 6
• 150000001875 compounds Chemical class 0.000 claims description 6
• 108091008042 inhibitory receptors Proteins 0.000 claims description 6
• 206010025135 lupus erythematosus Diseases 0.000 claims description 6
• 206010020751 Hypersensitivity Diseases 0.000 claims description 5
• 239000003814 drug Substances 0.000 claims description 5
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 claims description 4
• 206010002556 Ankylosing Spondylitis Diseases 0.000 claims description 4
• 241000282693 Cercopithecidae Species 0.000 claims description 4
• 206010009900 Colitis ulcerative Diseases 0.000 claims description 4
• 208000011231 Crohn disease Diseases 0.000 claims description 4
• 206010012438 Dermatitis atopic Diseases 0.000 claims description 4
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 4
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims description 4
• 102100037850 Interferon gamma Human genes 0.000 claims description 4
• 108010074328 Interferon-gamma Proteins 0.000 claims description 4
• 108010002352 Interleukin-1 Proteins 0.000 claims description 4
• 108010065805 Interleukin-12 Proteins 0.000 claims description 4
• 108050003558 Interleukin-17 Proteins 0.000 claims description 4
• 108010002350 Interleukin-2 Proteins 0.000 claims description 4
• 108010065637 Interleukin-23 Proteins 0.000 claims description 4
• 108090001005 Interleukin-6 Proteins 0.000 claims description 4
• 201000004681 Psoriasis Diseases 0.000 claims description 4
• 208000021386 Sjogren Syndrome Diseases 0.000 claims description 4
• 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 4
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims description 4
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims description 4
• 201000006704 Ulcerative Colitis Diseases 0.000 claims description 4
• 201000008937 atopic dermatitis Diseases 0.000 claims description 4
• 210000004027 cell Anatomy 0.000 claims description 4
• 208000027866 inflammatory disease Diseases 0.000 claims description 4
• 230000005764 inhibitory process Effects 0.000 claims description 4
• 108010074109 interleukin-22 Proteins 0.000 claims description 4
• 208000002551 irritable bowel syndrome Diseases 0.000 claims description 4
• 208000008795 neuromyelitis optica Diseases 0.000 claims description 4
• 208000007465 Giant cell arteritis Diseases 0.000 claims description 3
• 201000001263 Psoriatic Arthritis Diseases 0.000 claims description 3
• 208000036824 Psoriatic arthropathy Diseases 0.000 claims description 3
• 206010047115 Vasculitis Diseases 0.000 claims description 3
• 230000003828 downregulation Effects 0.000 claims description 3
• 229940079593 drug Drugs 0.000 claims description 3
• 201000006417 multiple sclerosis Diseases 0.000 claims description 3
• 206010043207 temporal arteritis Diseases 0.000 claims description 3
• 102000008203 CTLA-4 Antigen Human genes 0.000 claims description 2
• 108010021064 CTLA-4 Antigen Proteins 0.000 claims description 2
• 229940045513 CTLA4 antagonist Drugs 0.000 claims description 2
• 208000015943 Coeliac disease Diseases 0.000 claims description 2
• 102000004190 Enzymes Human genes 0.000 claims description 2
• 108090000790 Enzymes Proteins 0.000 claims description 2
• 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 claims description 2
• 101710083479 Hepatitis A virus cellular receptor 2 homolog Proteins 0.000 claims description 2
• 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 2
• 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 2
• 102000017578 LAG3 Human genes 0.000 claims description 2
• 101150030213 Lag3 gene Proteins 0.000 claims description 2
• 208000005777 Lupus Nephritis Diseases 0.000 claims description 2
• 241000283984 Rodentia Species 0.000 claims description 2
• 229940126547 T-cell immunoglobulin mucin-3 Drugs 0.000 claims description 2
• 206010046851 Uveitis Diseases 0.000 claims description 2
• 230000000172 allergic effect Effects 0.000 claims description 2
• 230000007815 allergy Effects 0.000 claims description 2
• 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 claims description 2
• 208000010668 atopic eczema Diseases 0.000 claims description 2
• 239000002738 chelating agent Substances 0.000 claims description 2
• 208000004921 cutaneous lupus erythematosus Diseases 0.000 claims description 2
• 230000002222 downregulating effect Effects 0.000 claims description 2
• 239000003937 drug carrier Substances 0.000 claims description 2
• 210000002865 immune cell Anatomy 0.000 claims description 2
• 239000002184 metal Substances 0.000 claims description 2
• 230000025020 negative regulation of T cell proliferation Effects 0.000 claims description 2
• 230000007302 negative regulation of cytokine production Effects 0.000 claims description 2
• 210000003289 regulatory T cell Anatomy 0.000 claims description 2
• 230000004044 response Effects 0.000 claims description 2
• 206010039073 rheumatoid arthritis Diseases 0.000 claims description 2
• 201000000596 systemic lupus erythematosus Diseases 0.000 claims description 2
• 230000003827 upregulation Effects 0.000 claims description 2
• 206010003230 arteritis Diseases 0.000 claims 2
• 238000004519 manufacturing process Methods 0.000 claims 2
• 108010047041 Complementarity Determining Regions Proteins 0.000 claims 1
• 230000001276 controlling effect Effects 0.000 claims 1
• 230000001185 psoriatic effect Effects 0.000 claims 1
• 208000011580 syndromic disease Diseases 0.000 claims 1
• 238000000034 method Methods 0.000 description 110
• 150000001413 amino acids Chemical class 0.000 description 2
• 230000002238 attenuated effect Effects 0.000 description 2
• 206010003246 arthritis Diseases 0.000 description 1
• 239000003795 chemical substances by application Substances 0.000 description 1
• 201000003068 rheumatic fever Diseases 0.000 description 1
• 230000002123 temporal effect Effects 0.000 description 1